Skip to main content
Current Medicinal Chemistry covers all the latest and outstanding developments in medicinal chemistry and rational drug design. Each issue contains a series of timely in-depth reviews written by leaders in the field covering a range of the current topics in medicinal chemistry. Current Medicinal Chemistry is an essential journal for every medicinal chemist who wishes to be kept informed and up-to-date with the latest and most important developments.

Publisher: Bentham Science Publishers

More about this publication?
Volume 18, Number 6, 2011

Articles

Anticancer Active Illudins: Recent Developments of a Potent Alkylating Compound Class
pp. 790-807(18)
Authors: Schobert, R.; Knauer, S.; Seibt, S.; Biersack, B.

Favourites:
ADD

Natural Products as Anti-Invasive and Anti-Metastatic Agents
pp. 808-829(22)
Authors: Jiang, Y.-L.; Liu, Z.-P.

Favourites:
ADD

New Targets for Antibacterial Design: Kdo Biosynthesis and LPS Machinery Transport to the Cell Surface
pp. 830-852(23)
Authors: Cipolla, L.; Polissi, A.; Airoldi, C.; Gabrielli, L.; Merlo, S.; Nicotra, F.

Favourites:
ADD

Road Towards New Antimalarials - Overview of the Strategies and their Chemical Progress
pp. 853-871(19)
Authors: Wu, Tao; S. Nagle, Advait; K. Chatterjee, Arnab

Favourites:
ADD

Pleiotropic Effects of Cardioactive Glycosides
pp. 872-885(14)
Authors: Riganti, C.; Campia, I.; Kopecka, J.; Gazzano, E.; Doublier, S.; Aldieri, E.; Bosia, A.; Ghigo, D.

Favourites:
ADD
Favourites:
ADD

Emerging Targets for the Treatment of Dyslipidemia
pp. 909-922(14)
Authors: Tavridou, A.; Ragia, G.; G. Manolopoulos, V.

Favourites:
ADD

How to Generate Reliable and Predictive CoMFA Models
pp. 923-930(8)
Authors: Zhang, Lei; Tsai, Keng-Chang; Du, Lupei; Fang, Hao; Li, Minyong; Xu, Wenfang

Favourites:
ADD

Emerging Role of Antioxidants in the Protection of Uveitis Complications
pp. 931-942(12)
Authors: C.S. Yadav, U.; M. Kalariya, N.; V. Ramana, K.

Favourites:
ADD

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content